title: Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer.
abstract: Endometrial cancer is the most frequent cancer of female genital tract. Metro- and menorrhagia or postmenopausal bleeding results in its early presentation. It allows radical treatment. However, controversies remain on surgery coverage or adjuvant therapies in early endometrial women cancer. Optimal management should minimize intervention instead of aggressive approach, as showed by recent studies. There is a role for brachytherapy as an adjuvant irradiation. Crucial publications including PORTEC-1, GOG 99, MRC ASTEC, ASTEC/EN.5, PORTEC-2 or Italian lymphadenectomy trial are discussed. Moreover, there is attention paid on adjuvant vaginal brachytherapy analyses for the past fifteen years.
authors: Brachytherapy Department, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland.
authors: Sylwia
authors: S
authors: Kellas-Ślęczka
authors: Piotr
authors: P
authors: Wojcieszek
authors: Brygida
authors: B
authors: Białas
keywords: HDR; LDR; brachytherapy; endometrial cancer; vaginal cylinder; vaginal vault
references: Gynecol Oncol. 1998 Oct;71(1):72-6
references: 9784322
references: Gynecol Oncol. 2007 Jul;106(1):215-20
references: 17482665
references: Br J Cancer. 2011 Apr 26;104(9):1505-10
references: 21522151
references: Lancet. 2010 Apr 3;375(9721):1165-72
references: 20188410
references: Arch Med Sci. 2010 Dec;6(6):937-44
references: 22427770
references: Gynecol Oncol. 1999 Oct;75(1):103-7
references: 10502434
references: J Clin Oncol. 2011 May 1;29(13):1692-700
references: 21444867
references: Int J Gynaecol Obstet. 2012 Oct;119 Suppl 2:S110-7
references: 22999502
references: Int J Gynecol Cancer. 2010 Oct;20(7):1166-9
references: 21495220
references: Eur J Cancer. 2010 Sep;46(13):2422-31
references: 20619634
references: Obstet Gynecol. 1980 Oct;56(4):419-27
references: 6999399
references: Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):417-25
references: 10661349
references: J Contemp Brachytherapy. 2012 Sep;4(3):135-40
references: 23346142
references: Am J Obstet Gynecol. 2011 Dec;205(6):562.e1-9
references: 22030315
references: Gynecol Oncol. 2010 Mar;116(3):404-7
references: 19944453
references: Gynecol Oncol. 1983 Feb;15(1):10-7
references: 6822361
references: Lancet. 2009 Jan 10;373(9658):125-36
references: 19070889
references: Lancet. 2010 Mar 6;375(9717):816-23
references: 20206777
references: Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):373-80
references: 9226326
references: Gynecol Oncol. 2008 Jan;108(1):226-33
references: 17996926
references: Obstet Gynecol Int. 2012;2012:578490
references: 22685466
references: Gynecol Oncol. 2005 Sep;98(3):434-8
references: 16005498
references: Ugeskr Laeger. 1997 May 26;159(22):3403-7
references: 9199028
references: Gynecol Oncol. 2004 Mar;92(3):744-51
references: 14984936
references: Gynecol Oncol. 2005 Jun;97(3):887-92
references: 15943991
references: J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16
references: 19033573
references: Eur J Cancer. 2012 Jul;48(11):1638-48
references: 22176868
references: Int J Gynecol Cancer. 2011 Oct;21(7):1180-4
references: 21795987
references: Lancet. 2000 Apr 22;355(9213):1404-11
references: 10791524
references: Lancet. 2009 Jan 10;373(9658):137-46
references: 19070891
references: Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7
references: 15850910
references: Br J Cancer. 2006 Aug 7;95(3):266-71
references: 16868539
references: Gynecol Oncol. 2012 Nov;127(2):332-7
references: 22910695